Hematology News‘Achilles heels’ open doors to myeloma advancesOctober 19, 2016Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology TimesSupportive care isn’t palliative care, speaker saysOctober 8, 2016Lymphoma & Plasma Cell DisordersMultiple MyelomaHematology Nursing
Hematology TimesStudy shows RT underused in developing countriesSeptember 29, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology NewsASPIRE trial: carfilzomib boosts quality of life in relapsed MMSeptember 27, 2016Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology TimesCells might protect cancer patients from infectionSeptember 27, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology TimesPatients may have high expectations of phase 1 trialsSeptember 26, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology Nursing
Hematology TimesDying cancer patients may be under-treated for painSeptember 21, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingRelated Issues
Hematology TimesCancer report details progress, predicts problemsSeptember 21, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingPediatricsRelated IssuesHodgkin Lymphoma
Hematology TimesCHMP recommends approval of ixazomib for MMSeptember 18, 2016Multiple MyelomaPharmacy
Hematology TimesMRD status should be endpoint in MM trials, team saysSeptember 16, 2016Multiple Myeloma
